1.Survey of the training among community health service staff in Guangdong province
Weiguang YAO ; Guowen WEI ; Aiguang XU ; Liyan QIU ; Zhuo CHEN ; Hongyan YU
Chinese Journal of Medical Education Research 2011;10(9):1136-1138
ObjectiveTo learn the status quo of pre-job training,on-the-job training and the demands of training among community health service staff,and to provide evidence of continuing education.MethodsInvestigation was made by self-designed questionnaire in 335 community health service staff from ten service centers and seven service stations in four regions of Guangdong province.Results The rate of pre-job training and on-the-job training were lower than the training demands among community health service staff.The content of on-the-job training was varied and could meet the training needs.Training was maily done in superior hospitals and the main form of training was seminars and classroom teaching.ConclusionTraining efforts should be increased to meet the training demands.Training model should be innovated to improve the training effect.Hospital and community exchanges should be strengthened and the training system should be improved.
2.Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer.
Aiguang ZHAO ; Wen CAO ; Yan XU ; Gang ZHAO ; Bingya LIU ; Yong CAI ; Jinzu YANG ; Ying GU ; Wei YUAN ; Yingjie ZHU ; Yingying HAN ; Jinyun YANG
Journal of Integrative Medicine 2010;8(3):224-30
Gastric cancer is one of the most common malignant tumors. Traditional Chinese medicine (TCM) has been widely used in treatment of gastric cancer, but still lacking large sample controlled trial to evaluate its efficacy.
3.Analysis of adverse events related to linezolid in tuberculosis treatment based on the US FAERS database
Yonghong ZOU ; Honglan ZHONG ; Duohua SU ; Aiguang XU ; Yi FANG
Modern Hospital 2024;24(10):1554-1556,1559
Objective To analyze the adverse events(AEs)associated with linezolid in tuberculosis treatment reported in the FDA Adverse Event Reporting System(FAERS)database,assess its safety profile,and provide scientific evidence for ra-tional clinical use.Methods Reports of adverse events related to linezolid in tuberculosis treatment from Q1 2016 to Q1 2024 were extracted.The data were cleaned and pre-processed,and signal detection was performed using the Reporting Odds Ratio(ROR)and Information Component(IC)methods.Results A total of 1,135 linezolid-related AEs were identified,with the most common types being hospitalization(18.46%)and death(10.99%).The Results indicated that linezolid AEs primarily involved disorders of the blood and lymphatic system,as well as liver and biliary system diseases.Common adverse reactions in-cluded anemia,peripheral neuropathy,and optic neuropathy.Additionally,some adverse reaction signals not mentioned in the prescribing information were identified,such as polyneuropathy(ROR=75.25,IC025=5.8),toxic optic neuropathy(ROR=776.95,IC025=8.86),and hearing loss(ROR=14.66,IC025=3.26).Conclusion This study suggests that linezolid may be associated with some serious adverse reactions in tuberculosis treatment.It is recommended that patients on long-term linezolid therapy undergo regular neurological,ophthalmological,and auditory assessments to provide a more adequate basis for rational clinical use.